References
- Derfus AM, Chan WCW, Bhatia SN. 2004. Probing the cytotoxicity of semiconductor quantum dots. Nano Lett. 4:11–18.
- Erogbogbo F, Tien C-A, Chang C-W, Yong K-T, Law W-C, Ding H, et al. 2011. Bioconjugation of luminescent silicon quantum dots for selective uptake by cancer cells. Bioconjug Chem. 22:1081–1088.
- Fonseca SB, Pereira MP, Kelley SO. 2009. Recent advances in the use of cell-penetrating peptides for medical and biological applications. Adv Drug Deliv Rev. 61:953–964.
- Goldman ER, Balighian ED, Mattoussi H, Kuno MK, Mauro JM, Tran PT, Anderson GP. 2002. Avidin: a natural bridge for quantum dot-antibody conjugates. J Am Chem Soc. 124:6378–6382.
- Jamieson T, Bakhshi R, Petrova D, Pocock R, Imani M, Seifalian AM. 2007. Biological applications of quantum dots. Biomaterials. 28:4717–4732.
- Larson DR, Zipfel WR, Williams RM, Clark SW, Bruchez MP, Wise FW, Webb WW. 2003. Water-soluble quantum dots for multiphoton fluorescence imaging in vivo. Science. 300:1434–1436.
- Lindgren M, Langel Ü. 2011. Classes and prediction of cell-penetrating peptides. Cell-Penetrating Peptides: Springer; p. 3–19.
- Liu BR, Huang Y-w, Winiarz JG, Chiang H-J, Lee H-J. 2011. Intracellular delivery of quantum dots mediated by a histidine-and arginine-rich HR9 cell-penetrating peptide through the direct membrane translocation mechanism. Biomaterials. 32:3520–3537.
- Liu BR, Li J-F, Lu S-W, Lee H-J, Huang Y-W, Shannon KB, et al. 2010. Cellular internalization of quantum dots noncovalently conjugated with arginine-rich cell-penetrating peptides. J Nanosci Nanotechnol. 10:6534–6543.
- Michalet X, Pinaud FF, Bentolila LA, Tsay JM, Doose S, Li JJ, et al. 2005. Quantum dots for live cells, in vivo imaging, and diagnostics. Science. 307:538–544.
- Resch-Genger U, Grabolle M, Cavaliere-Jaricot S, Nitschke R, Nann T. 2008. Quantum dots versus organic dyes as fluorescent labels. Nat Methods. 5:763–775.
- Rydberg HA, Matson M, Åmand HL, Esbjörner EK, Nordén B. 2012. Effects of tryptophan content and backbone spacing on the uptake efficiency of cell-penetrating peptides. Biochemistry. 51: 5531–5539.
- Snyder EL, Dowdy SF. 2004. Cell penetrating peptides in drug delivery. Pharm Res. 21:389–393.
- Temsamani J, Vidal P. 2004. The use of cell-penetrating peptides for drug delivery. Drug Discov Today. 9:1012–1019.
- Tünnemann G, Ter‐Avetisyan G, Martin RM, Stöckl M, Herrmann A, Cardoso MC. 2008. Live‐cell analysis of cell penetration ability and toxicity of oligo‐arginines. J Pept Sci. 14:469–476.
- William WY, Chang E, Drezek R, Colvin VL. 2006. Water-soluble quantum dots for biomedical applications. Biochem Biophys Res Commun. 348:781–786.
- Xu Y, Liu BR, Lee H-J, Shannon KB, Winiarz JG, Wang T-C, et al. 2010. Nona-arginine facilitates delivery of quantum dots into cells via multiple pathways. J BioMed Res Int. 2010.
- Zorko M, Langel Ü. 2005. Cell-penetrating peptides: mechanism and kinetics of cargo delivery. Adv Drug Deliv Rev. 57:529–545.